Repligen Corporation (RGEN)

NASDAQ


Symbol		Exchange		Currency
RGEN	·	NASDAQ	·	USD	Real-time
1RGEN	·	Milan	·	EUR	Real-time
RGEN	·	TradeGate	·	EUR	Delayed

Currency in USD

RGEN Pro Research

132.70

+0.71(+0.54%)

Closed·21/04

After Hours

135.29+2.59(+1.95%)

·21/04

Fair Value

Unlock Value

Day's Range

131.30

141.46

52 wk Range

109.66

175.77

RGEN Income Statement

Assess the Repligen income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the RGEN net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

670.53

801.54

632.36

634.44

738.26

Total Revenues Growth

aa.aa

+83.08%

+19.54%

-21.11%

+0.33%

+16.36%

Cost Of Revenues

aa.aa

279.28

345.83

323.54

315.77

349.54

Gross Profit

aa.aa

391.25

455.71

308.83

318.67

388.71

Gross Profit Growth

aa.aa

+85.99%

+16.47%

-32.23%

+3.19%

+21.98%

Gross Profit Margin %

aa.aa

58.35%

56.85%

48.84%

50.23%

52.65%

Other Operating Expenses, Total

aa.aa

218.14

259.77

259.49

281.03

343.02

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+60.63%	+19.08%	-0.11%	+8.3%	+22.06%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	34.27	43.94	42.61	42.75	53.38
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	183.87	215.83	216.89	238.28	289.64
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

173.11

195.94

49.33

37.65

45.7

Operating Income Growth

aa.aa

+132.19%

+13.19%

-74.82%

-23.69%

+21.38%

EBIT Margin %

aa.aa

25.82%

24.45%

7.8%

5.93%

6.19%

Net Interest Expenses

aa.aa

-12.54

13.56

13.25

4.4

Net Interest Expenses Growth

aa.aa

-20.65%

+131.91%

+238.84%

-2.24%

-66.79%

Interest Expense, Total

aa.aa

-12.71

-2.98

-10.58

-22.57

-23.17

Interest And Investment Income

aa.aa

0.18

6.98

24.14

35.83

27.57

Other Non Operating Expenses, Total

aa.aa

-1.17

-9.53

8.12

-5.41

2.82

EBT, Excl. Unusual Items

aa.aa

159.41

190.41

71.01

45.49

52.91

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-5.87

28.73

17.89

-25.59

13.61

EBT, Incl. Unusual Items

aa.aa

153.54

219.14

56.71

-27.04

62.38

EBT, Incl. Unusual Items Growth

aa.aa

+159.29%

+42.72%

-74.12%

-147.67%

+330.75%

EBT, Incl. Unusual Items Margin

aa.aa

22.9%

27.34%

8.97%

-4.26%

8.45%

Income Tax Expense

aa.aa

25.25

33.18

21.11

-1.52

13.49

Net Income to Company

aa.aa

128.29

185.96

35.6

-25.51

48.89

Minority Interest

aa.aa

Net Income

aa.aa

128.29

185.96

35.6

-25.51

48.89

Net Income Growth

aa.aa

+114.08%

+44.95%

-80.86%

-171.68%

+291.64%

Net Income Margin %

aa.aa

19.13%

23.2%

5.63%

-4.02%

6.62%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

128.29

185.96

35.6

-25.51

48.89

Basic EPS - Continuing Operations

aa.aa

2.33

3.35

0.64

-0.46

0.87

Basic EPS - Continuing Operations Growth

aa.aa

+104.51%

+43.79%

-80.95%

-171.4%

+290.62%

Diluted EPS - Continuing Operations

aa.aa

2.24

3.24

0.63

-0.46

0.86

Diluted EPS - Continuing Operations Growth

aa.aa

+101.8%

+44.79%

-80.58%

-173.02%

+286.96%

Basic Weighted Average Shares Outstanding

aa.aa

55.02

55.46

55.72

55.94

56.23

Diluted Weighted Average Shares Outstanding

aa.aa

57.26

57.46

56.38

55.94

56.56

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

211.56

246.93

114.07

107.3

124.44

EBITDA Growth

aa.aa

+108.18%

+16.72%

-53.8%

-5.94%

+15.97%

EBITDA Margin %

aa.aa

31.55%

30.81%

18.04%

16.91%

16.86%

EBIT

aa.aa

173.11

195.94

49.33

37.65

45.7

* In Millions of USD (except for per share items)

FAQ

What was Repligen’s revenue at year end?

At the end of the last reported fiscal year, Repligen (RGEN) recorded total revenue of 738.26 million USD.

How much revenue did Repligen report in the most recent quarter?

In its most recent quarterly earnings report, Repligen posted revenue of 197.91 million USD.

What was Repligen’s net income for the year?

For the full year, Repligen reported net income of 48.89 million USD.

How much net income did Repligen post in the last quarter?

In the most recent quarter, Repligen (RGEN) posted net income of 13.29 million USD.

What was Repligen’s gross profit for the year?

Gross profit for the year was reported at 388.71 million USD.

How much gross profit did Repligen generate last quarter?

Repligen recorded gross profit of 103.83 million USD in its latest quarterly report.

What was Repligen’s annual operating income?

For the full year, Repligen (RGEN) reported operating income of 45.70 million USD.

What was Repligen’s operating income last quarter?

Quarterly operating income was 16.35 million USD.

What was Repligen’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 36.30 million USD.

What was the quarter-over-quarter change in EBITDA for Repligen?

EBITDA changed by 11.05% million USD compared to the last quarter.

What is Repligen’s most recent gross profit margin?

The latest reported gross profit margin for Repligen (RGEN) is 52.46% million USD.

What is Repligen’s most recent net income margin?

Net income margin based on recent financials is 6.71% million USD.

What is Repligen’s most recent EBIT margin?

Repligen reported an EBIT margin of 8.26% million USD based on current figures.

How did Repligen’s revenue change compared to the previous quarter?

Revenue changed by 4.82% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Repligen?

In the latest quarter, gross profit changed by 3.30% million USD from the previous quarter.

S&P/TSX

33,808.30

-551.73

-1.61%

S&P/TSX 60

1,972.35

-25.69

-1.29%

US 30

49,435.90

+286.3

+0.58%

US 500

7,108.20

+44.2

+0.63%

S&P 500 VIX

19.50

+0.63

+3.34%

DAX

24,270.87

-146.93

-0.60%

Dollar Index

98.122

-0.099

-0.10%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	60.55	+2.57%	19.79M
RBC	242.81	-1.24%	7.29M
TC Energy	82.21	-0.99%	6.49M
Enbridge	70.98	-0.48%	5.87M
Suncor Energy	85.73	+1.93%	4.96M
Canadian Imperial Bank	148.48	-1.27%	3.14M
Agnico Eagle Mines	277.52	-6.08%	1.64M

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.04	+700.00%	11.33K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Rivalry	0.01	+200.00%	220.50K
Irwin Naturals	0.30	+150.00%	3.24K
Global Health Clinics	0.070	+133.33%	5.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Mayfair Acquisition	0.02	-80.00%	20.00K
New Frontier Ventures	0.030	-68.42%	13.00K
Moss Genomics	0.03	-57.14%	2.00K
CordovaCann	0.0150	-57.14%	22.00K
CAT Strategic	0.0050	-50.00%	1.30K
Winchester Equity	0.02	-50.00%	6.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Canadian Natural	60.55	+2.57%	19.79M
TELUS	16.82	-0.12%	5.43M
Hut 8	104.680	-2.90%	819.81K
Keel Infra	3.85	-1.53%	3.16M
Celestica Inc.	551.56	+0.74%	674.94K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aaaaaaa Aaa A	5.28	+61.25%	8.51
Aaaaa A Aaaaa	105.11	+48.58%	156.17
Aaaaaaaaaaaaa Aaaa	43.51	+48.02%	64.40
Aaaaa Aaaaaaaaaaa	115.27	+44.34%	166.38
Aaaaa Aaaaaaaaa Aa	6.46	+44.14%	9.31
A Aaaaaa Aa Aaa Aa	23.01	+42.54%	32.80
Aaa Aaaaaaa Aa	261.33	+38.56%	362.10

Name	Last	Upside	Fair Value
Aaaa Aaaaaaa Aaa A	5.28	+61.25%	8.51
Aaaaa A Aaaaa	105.11	+48.58%	156.17
Aaaaaaaaaaaaa Aaaa	43.51	+48.02%	64.40
Aaaaa Aaaaaaaaaaa	115.27	+44.34%	166.38
Aaaaa Aaaaaaaaa Aa	6.46	+44.14%	9.31
A Aaaaaa Aa Aaa Aa	23.01	+42.54%	32.80
Aaa Aaaaaaa Aa	261.33	+38.56%	362.10

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Repligen Corporation (RGEN)

RGEN Income Statement

FAQ

What was Repligen’s revenue at year end?

How much revenue did Repligen report in the most recent quarter?

What was Repligen’s net income for the year?

How much net income did Repligen post in the last quarter?

What was Repligen’s gross profit for the year?

How much gross profit did Repligen generate last quarter?

What was Repligen’s annual operating income?

What was Repligen’s operating income last quarter?

What was Repligen’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Repligen?

What is Repligen’s most recent gross profit margin?

What is Repligen’s most recent net income margin?

What is Repligen’s most recent EBIT margin?

How did Repligen’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Repligen?

Trending Stocks